These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22196854)

  • 1. Emerging cellular targets for influenza antiviral agents.
    Müller KH; Kakkola L; Nagaraj AS; Cheltsov AV; Anastasina M; Kainov DE
    Trends Pharmacol Sci; 2012 Feb; 33(2):89-99. PubMed ID: 22196854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs.
    An L; Liu R; Tang W; Wu JG; Chen X
    Antiviral Res; 2014 Sep; 109():54-63. PubMed ID: 24971493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral effect of strictinin on influenza virus replication.
    Saha RK; Takahashi T; Kurebayashi Y; Fukushima K; Minami A; Kinbara N; Ichitani M; Sagesaka YM; Suzuki T
    Antiviral Res; 2010 Oct; 88(1):10-8. PubMed ID: 20615432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antivirals for influenza: historical perspectives and lessons learned.
    Hayden FG
    Antiviral Res; 2006 Sep; 71(2-3):372-8. PubMed ID: 16815563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.
    Perwitasari O; Yan X; O'Donnell J; Johnson S; Tripp RA
    Assay Drug Dev Technol; 2015 Dec; 13(10):638-49. PubMed ID: 26192013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity and possible mechanisms of action of pentagalloylglucose (PGG) against influenza A virus.
    Liu G; Xiong S; Xiang YF; Guo CW; Ge F; Yang CR; Zhang YJ; Wang YF; Kitazato K
    Arch Virol; 2011 Aug; 156(8):1359-69. PubMed ID: 21479599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin A1 inhibits avian influenza virus replication at a postentry level: Effect on virus protein synthesis and NF-κB activity.
    Carta S; La Frazia S; Donatelli I; Puzelli S; Rossi A; Santoro MG
    Prostaglandins Leukot Essent Fatty Acids; 2014 Dec; 91(6):311-23. PubMed ID: 25151089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide inhibitors against influenza virus.
    Rajik M; Yusoff K
    Antivir Chem Chemother; 2011 Mar; 21(4):151-4. PubMed ID: 21602612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza drug resistance.
    Pizzorno A; Abed Y; Boivin G
    Semin Respir Crit Care Med; 2011 Aug; 32(4):409-22. PubMed ID: 21858746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening methods for influenza antiviral drug discovery.
    Atkins C; Evans CW; White EL; Noah JW
    Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs.
    Chen SC; Jeng KS; Lai MMC
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The substances active against influenza virus. Possibilities and prospects of application].
    Kwiatek M; Kocik J; Bartoszcze M
    Przegl Epidemiol; 2009; 63(4):487-94. PubMed ID: 20120945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promise of siRNAs for the treatment of influenza.
    Bennink JR; Palmore TN
    Trends Mol Med; 2004 Dec; 10(12):571-4. PubMed ID: 15567323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression.
    Schräder T; Dudek SE; Schreiber A; Ehrhardt C; Planz O; Ludwig S
    Antiviral Res; 2018 Sep; 157():80-92. PubMed ID: 29990517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JNJ872 inhibits influenza A virus replication without altering cellular antiviral responses.
    Fu Y; Gaelings L; Söderholm S; Belanov S; Nandania J; Nyman TA; Matikainen S; Anders S; Velagapudi V; Kainov DE
    Antiviral Res; 2016 Sep; 133():23-31. PubMed ID: 27451344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Influenza Activity of the Ribonuclease Binase: Cellular Targets Detected by Quantitative Proteomics.
    Ulyanova V; Shah Mahmud R; Laikov A; Dudkina E; Markelova M; Mostafa A; Pleschka S; Ilinskaya O
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of drug-resistant influenza virus: population dynamical considerations.
    Regoes RR; Bonhoeffer S
    Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
    Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
    J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.